Basal Ganglia Diseases

Download PDF

Recent Publications on Basal Ganglia Diseases:
[Acute extrapyramidal syndrome and neuroleptical malignant syndrome. A case report] A case of serious undesirable, effect arisen in a 24-year old male treated...	4th July, 2008	Servizio Psichiatrico Diagnosi e Cura, Ospedale di Caprino Veronese,	Recenti Prog Med. 2008 Mar;99(3):146-8.
Problems with CATIE. Phase 1: Looking back--what the clinician needs to know. A case of serious undesirable, effect arisen in a 24-year old male treated...	3rd July, 2008	Hartford Hospital/The Institute of Living, 80 Seymour Street, P.O. Box	Conn Med. 2008 Apr;72(4):223-6.
White matter changes in corticobasal degeneration syndrome and correlation with limb apraxia. BACKGROUND: Data on white matter changes in corticobasal degeneration...	27th June, 2008	Department of Neurology, University of Brescia, Brescia, Italy.	Arch Neurol. 2008 Jun;65(6):796-801. DOI Direct Link
Safety profile of iloperidone: a pooled analysis of 6-week acute-phase pivotal trials. Iloperidone, a mixed D2/5-HT2 antagonist, is currently in clinical...	27th June, 2008	Center for Cognitive Medicine, Chicago, IL 60612, USA.	J Clin Psychopharmacol. 2008 Apr;28(2 Suppl 1):S12-9. DOI Direct Link
A 12-month, open-label, comparative study of quetiapine and risperidone in the acute and long-term treatment of schizophrenia. This multicentre, observational, prospective, nonrandomized study compared...	27th June, 2008	Department of Psychiatry, Hospital de la Sta Creu i Sant Pau, Barcelona	Int Clin Psychopharmacol. 2008 May;23(3):138-49. DOI Direct Link
→View more research publications.

Basal Ganglia Diseases Clinical Trials:
A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of Melanoma	Parkinsons Disease;   Malignant Melanoma
Cell Studies of Parkinson's Disease	Parkinson Disease
Open Label Sumanirole Study of Safety, Tolerability, and Therapeutic Response In Patients With Parkinson's Disease	Parkinson Disease
Long-Term Extension Study Evaluating Extended Release Ropinirole XL (Formerly Referred to as Ropinirole CR) in Patients Who Already Completed Either Study 167 or 164	Parkinson's Disease
Namenda (Memantine) for Non-Motor Symptoms in Parkinson's Disease	Parkinson's Disease
→View more trials.

Basal Ganglia Diseases Patents:
US Patent No.	Title
7235529	Brain-associated inhibitor of tissue-type plasminogen activator
5322682	Method for quantitatively measuring and mapping stored iron in tissue using MRI
5393784	Treatment of tardive dyskinesia with leucine, isoleucine, valine or mixtures thereof
5670539	Treatment of movement disorders using large neutral amino acids
5919823	Treatment of secondary movement disorders using large neutral amino acids
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Basal Ganglia Diseases scientists - we have details of around 407 individuals working on Basal Ganglia Diseases .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.